HR 5219
114th Congress
House
Health
Administrative law and regulatory procedures
Advisory bodies
Child health
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Medical ethics
Medical research
Prescription drugs
Research administration and funding
Women's health
Safe Medications for Moms and Babies Act of 2016
Introduced: May 12, 2016
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 13, 2016
Referred to the Subcommittee on Health.
May 12, 2016
Referred to the House Committee on Energy and Commerce.
May 12, 2016
Introduced in House
Plain-English summary
Safe Medications for Moms and Babies Act of 2016
This bill requires the Department of Health and Human Services to establish the Task Force on Research Specific to Pregnant Women and Lactating Women to report on issues including: (1) the development of safe and effective therapies for such women, (2) ethical issues surrounding the inclusion of such women in clinical research, and (3) federal research activities regarding such women.
The Food and Drug Administration must report specified information including the number of new drugs approved based on research that included such women in clinical trials.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2